Pediatric Dosing

Body weight and body surface area provide patient-specific ways to relate a medication amount to a child’s size. Their relevance depends on the medication and clinical context, so clinicians consider them alongside age, organ function, and formulation or concentration. Using the appropriate size-related measure helps reduce the risk that treatment delivers too little or excessive drug exposure.

Age reflects developmental differences that can influence how a medication is absorbed, distributed, metabolized, and excreted. Infants, children, and adolescents may therefore experience different drug exposure from the same administered amount. Incorporating developmental context helps clinicians tailor therapy to the child rather than applying adult dosing assumptions without adjustment.

Organ function affects the body’s handling of medication, particularly its metabolism and excretion. Acute illness can also alter the clinical circumstances in which treatment is given, making the selected dose or schedule more consequential. Considering these factors supports adjustments intended to maintain effective exposure while limiting the possibility of toxicity during routine or urgent care.

The concentration and formulation determine how an intended medication amount is translated into an administered dose. Different formulations may present the drug in different concentrations, so clinicians must match the selected amount to the product being used. Careful attention to these characteristics supports accurate administration and helps prevent underdosing or excessive exposure.

Pharmacokinetics describes what happens to a medication as it is absorbed, distributed, metabolized, and excreted. Changes in any of these processes can alter how much drug reaches its site of action and how long it remains available. Applying this framework helps clinicians interpret why a dose that appears appropriate by size alone may not produce the expected exposure.

Individualized dosing is relevant across routine care, acute illness, and specialized therapies. In each setting, clinicians can integrate the child’s age, size, organ function, developmental physiology, and the medication’s formulation or concentration. This approach supports treatment goals while addressing the different risks of underdosing, ineffective exposure, and toxicity in pediatric patients.